Chemotherapy regimen choice and patient outcomes in early-stage triple-negative breast cancer: a retrospective analysis.
Sanaz N GhafouriRebecca W NayeriNicholas P McAndrewSara A HurvitzPublished in: Therapeutic advances in medical oncology (2022)
ABRs were associated with shorter EFS, DFS, and OS, even after adjusting for certain high-risk clinical features.